gracecast - lcvl can egfr inhibitor therapy treat and prevent brain metastases
Published 3 years ago • 69 plays • Length 8:58Download video MP4
Download video MP3
Similar videos
-
7:41
gracecast - lcvl - h. jack west md - can alk inhibitors treat and prevent brain metastases
-
6:31
gracecast - lcvl - what is the best first line treatment for patients with advanced egfr mutation-po
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
-
12:58
egfr inhibitor therapy in second line
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
7:35
treatment for patients with egfr nsclc - leading developments & current questions in lung cancer
-
9:18
gracecast - treatment options for metastatic nsclc
-
5:24
gracecast - lcvl - can immunotherapy help frail patients with advanced nsclc
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
8:09
gracecast - lcvl -can local therapies improve outcomes for stage iv nsclc?
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
14:43
gracecast-070_lung-cancer_q&a for acquired egfr tki and re-biopsying
-
6:38
asco lc highlights, pt 6: benefit of chemotherapy vs. egfr inhibitor therapy in second line
-
2:00
choosing first line therapy in egfr mutations
-
5:34
gracecastuc-038_lung_managing acq. resistance to egfr therapy (and probably crizotinib, too)
-
1:09:58
breakout second stage 2023 targeted therapies in lung cancer forum on-demand
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?